Action Point Financial Planning’s Emergent Biosolutions EBS Stock Holding History

Action Point Financial Planning’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11K	Buy	+1,308	New	+$10.9K	﹤0.01%	1416

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Action Point Financial Planning's EBS Position: Q2 2026 in Review

Action Point Financial Planning opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 1,308 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #1416 among its holdings.

194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Action Point Financial Planning held 1,308 shares of Emergent Biosolutions worth $11K as of Q2 2026.
Emergent Biosolutions was a new Action Point Financial Planning position in Q2 2026.
Emergent Biosolutions made up ﹤0.01% of Action Point Financial Planning's portfolio in Q2 2026, its #1416 holding.
194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Action Point Financial Planning's 13F filing for Q2 2026, filed 14 Aug 2026.